[February 03, 2016] |
|
Chronic Pain Therapeutics Pipeline Review, H2 2015 - Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/nzwtj5/chronic_pain)
has announced the addition of the "Chronic
Pain - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Chronic Pain, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Chronic
Pain and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Chronic Pain Overview
-
Therapeutics Development
-
Pipeline Products for Chroni Pain - Overview
-
Pipeline Products for Chronic Pain - Comparative Analysis
-
Chronic Pain - Therapeutics under Development by Companies
-
Chronic Pain - Therapeutics under Investigation by
Universities/Institutes
-
Chronic Pain - Pipeline Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Chronic Pain - Products under Development by Companies
-
Chronic Pain - Products under Investigation by Universities/Institutes
-
Chronic Pain - Companies Involved in Therapeutics Development
Companies Featured (Partial List)
-
AbbVie Inc.
-
Acadia Pharmaceuticals Inc.
-
Adynxx, Inc.
-
Allergan Plc
-
Amorsa Therapeutics Inc.
-
arGEN-X BV
-
AskAt Inc.
-
Astellas Pharma Inc.
-
Astraea Therapeutics, LLC
-
AstraZeneca Plc
-
BioDelivery Sciences International, Inc.
-
Bionomics Limited
-
Cara Therapeutics, Inc.
-
Charleston Laboratories, Inc.
-
ChironWells GmbH
-
Collegium Pharmaceutical, Inc.
-
CoLucid Pharmaceuticals, Inc.
-
Convergence (News - Alert) Pharmaceuticals Ltd.
-
Creabilis SA
-
Crinetics Pharmaceuticals, Inc.
-
Cyclenium Pharma, Inc.
-
Cytogel Pharma, LLC
-
Daewoong Pharmaceutical Co., Ltd.
-
Daiichi Sankyo Company, Limited
-
Dompe Farmaceutici S.p.A.
-
Echo Pharmaceuticals B.V.
-
Egalet Corporation
-
Eli Lilly and Company
-
Elite Pharmaceuticals, Inc.
-
Glenmark Pharmaceuticals Ltd.
-
Grunenthal GmbH
-
Heron Therapeutics, Inc.
-
INSYS Therapeutics, Inc.
-
Johnson & Johnson
-
Kareus Therapeutics, SA
For more information visit http://www.researchandmarkets.com/research/nzwtj5/chronic_pain
View source version on businesswire.com: http://www.businesswire.com/news/home/20160203006336/en/
[ Back To TMCnet.com's Homepage ]
|